The evolving definition of carcinogenic human papillomavirus

<p>Abstract</p> <p>Thirteen human papillomavirus (HPV) genotypes have been judged to be carcinogenic or probably carcinogenic, and the cause of virtually all cervical cancer worldwide. Other HPV genotypes could possibly be involved. Although the inclusion of possibly carcinogenic H...

Full description

Bibliographic Details
Main Author: Castle Philip E
Format: Article
Language:English
Published: BMC 2009-05-01
Series:Infectious Agents and Cancer
Online Access:http://www.infectagentscancer.com/content/4/1/7
id doaj-2845bbd660b646989ff626f25c778ae1
record_format Article
spelling doaj-2845bbd660b646989ff626f25c778ae12020-11-24T23:29:04ZengBMCInfectious Agents and Cancer1750-93782009-05-0141710.1186/1750-9378-4-7The evolving definition of carcinogenic human papillomavirusCastle Philip E<p>Abstract</p> <p>Thirteen human papillomavirus (HPV) genotypes have been judged to be carcinogenic or probably carcinogenic, and the cause of virtually all cervical cancer worldwide. Other HPV genotypes could possibly be involved. Although the inclusion of possibly carcinogenic HPV genotypes may hurt test specificity, it may indirectly increase the reassurance following a negative HPV test (i.e. the negative predictive value of an HPV test for cervical precancer and cancer). The future of cervical cancer screening in low-resource setting, however, may include once-in-a-lifetime, low-cost and rapid HPV testing. However, the tradeoff of more false positives for greater reassurance may not be acceptable if the local infrastructure cannot manage the screen positives. Now is the time for the community of scientists, doctors, and public health advocates to use the data presented at the 100th International Agency for Research on Cancer monograph meeting to rationally decide the target HPV genotypes for the next generation of HPV tests for use in high-resource and low-resource settings. The implications of including possibly HPV genotypes on HPV test performance, also for guidance on the use of these tests for cervical cancer prevention programs, are discussed.</p> http://www.infectagentscancer.com/content/4/1/7
collection DOAJ
language English
format Article
sources DOAJ
author Castle Philip E
spellingShingle Castle Philip E
The evolving definition of carcinogenic human papillomavirus
Infectious Agents and Cancer
author_facet Castle Philip E
author_sort Castle Philip E
title The evolving definition of carcinogenic human papillomavirus
title_short The evolving definition of carcinogenic human papillomavirus
title_full The evolving definition of carcinogenic human papillomavirus
title_fullStr The evolving definition of carcinogenic human papillomavirus
title_full_unstemmed The evolving definition of carcinogenic human papillomavirus
title_sort evolving definition of carcinogenic human papillomavirus
publisher BMC
series Infectious Agents and Cancer
issn 1750-9378
publishDate 2009-05-01
description <p>Abstract</p> <p>Thirteen human papillomavirus (HPV) genotypes have been judged to be carcinogenic or probably carcinogenic, and the cause of virtually all cervical cancer worldwide. Other HPV genotypes could possibly be involved. Although the inclusion of possibly carcinogenic HPV genotypes may hurt test specificity, it may indirectly increase the reassurance following a negative HPV test (i.e. the negative predictive value of an HPV test for cervical precancer and cancer). The future of cervical cancer screening in low-resource setting, however, may include once-in-a-lifetime, low-cost and rapid HPV testing. However, the tradeoff of more false positives for greater reassurance may not be acceptable if the local infrastructure cannot manage the screen positives. Now is the time for the community of scientists, doctors, and public health advocates to use the data presented at the 100th International Agency for Research on Cancer monograph meeting to rationally decide the target HPV genotypes for the next generation of HPV tests for use in high-resource and low-resource settings. The implications of including possibly HPV genotypes on HPV test performance, also for guidance on the use of these tests for cervical cancer prevention programs, are discussed.</p>
url http://www.infectagentscancer.com/content/4/1/7
work_keys_str_mv AT castlephilipe theevolvingdefinitionofcarcinogenichumanpapillomavirus
AT castlephilipe evolvingdefinitionofcarcinogenichumanpapillomavirus
_version_ 1725546684844343296